Browse our latest Cancer Biology articles

Page 35 of 94
    1. Cancer Biology
    2. Cell Biology

    ahctf1 and kras mutations combine to amplify oncogenic stress and restrict liver overgrowth in a zebrafish model of hepatocellular carcinoma

    Kimberly J Morgan, Karen Doggett ... Joan K Heath
    ELYS, a multifunctional protein with critical roles in the cell cycle, is essential for the vigorous proliferation and survival of difficult-to-treat cancers carrying mutations in the KRAS oncogene, making it a compelling target for novel drug treatments.
    1. Cancer Biology
    2. Microbiology and Infectious Disease

    Beta human papillomavirus 8E6 promotes alternative end joining

    Changkun Hu, Taylor Bugbee ... Nicholas Wallace
    Human papillomavirus type 8 E6 promotes alternative end joining by compromising non-homologous end joining and homologous recombination.
    1. Cancer Biology

    Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma

    Anthony Lozano, Francois-Régis Souche ... Damien Grégoire
    Specific tissue environments provide selective pressures that give rise to distinct Ras oncogenic dosage in primary liver tumours and their metastatic-like outgrowths.
    1. Cancer Biology
    2. Chromosomes and Gene Expression

    Inducible lncRNA transgenic mice reveal continual role of HOTAIR in promoting breast cancer metastasis

    Qing Ma, Liuyi Yang ... Howard Y Chang
    HOTAIR is required in an ongoing manner when it regulates epigenetic status and reprograms cancer cell gene expression in promoting breast cancer metastasis.
    1. Biochemistry and Chemical Biology
    2. Cancer Biology

    Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth

    Luca Costantino, Stefania Ferrari ... Maria Paola Costi
    The dimer destabilizers cause a dimer-to-monomer equilibrium shift favoring the human thymidylate synthase monomer more degradable by the proteasome, thus breaking the long-standing link between inhibition and enhanced expression of the protein to fight cancer drug resistance.
    1. Cancer Biology
    2. Immunology and Inflammation

    Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors

    Matheswaran Kandasamy, Uzi Gileadi ... Vincenzo Cerundolo
    Immunization with NY-ESO-1 S-FLU virus elicits a robust NY-ESO-1-specific CTL response and suppresses the NY-ESO-1-expressing tumour development and spontaneous metastasis.
    1. Cancer Biology

    EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression

    Zong-Shin Lin, Chiao-Chen Chung ... Ya-Huey Chen
    EZH2/cMET may serve as biomarkers to stratify chondrosarcoma patients for cMET inhibitor treatment.
    1. Cancer Biology

    Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer

    Jiawen Bu, Yixiao Zhang ... Caigang Liu
    Dalpiciclib could partially abrogate ER nuclear transportation induced by pyrotinib in HER2+HR+ breast cancer and CALML5 could serve as a potential risk factor in the treatment of HER2+HR+ breast cancer.
    1. Cancer Biology
    2. Computational and Systems Biology

    Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development

    Paul R Barber, Rami Mustapha ... Tony Ng
    Circulating immune cells reflect intra-tumoural immunity and can predict response to systemic therapy in head and neck cancer.
    1. Biochemistry and Chemical Biology
    2. Cancer Biology

    Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction

    Jacob M Winter, Heidi L Fresenius ... Jared Rutter
    A common genomic deletion in various human cancers disrupts mitochondrial protein homeostasis in a way that might be targeted by existing drugs.